Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-?B-inducing kinase while activating both canonical and alternative nuclear factor-?B pathways.

Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-?B-inducing kinase while activating both canonical and alternative nuclear factor-?B pathways. Blood. 2011 Jan 06; 117(1):200-10.

View in: PubMed

subject areas

Baculoviral IAP Repeat-Containing 3 Protein
B-Cell Activating Factor
B-Cell Activation Factor Receptor
Blotting, Western
Cell Nucleus
Cell Proliferation
Humans
I-kappa B Proteins
Immunoenzyme Techniques
Immunoprecipitation
Inhibitor of Apoptosis Proteins
Lymphoma, Large B-Cell, Diffuse
NF-kappa B
NF-KappaB Inhibitor alpha
Phosphorylation
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger
RNA, Small Interfering
Signal Transduction
Tissue Array Analysis
TNF Receptor-Associated Factor 2
TNF Receptor-Associated Factor 3
Ubiquitin-Protein Ligases

authors with profiles

CARLOS E BUESO-RAMOS
L JEFFREY MEDEIROS
LAN PHAM